Multiple Signals from Dysfunctional Mitochondria Activate the Pleiotropic Drug Resistance Pathway in Saccharomyces cerevisiae
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Multiple or pleiotropic drug resistance most often occurs in Saccharomyces cerevisiae due to substitution mutations within the Cys(6)-Zn(II) transcription factors Pdr1p and Pdr3p. These dominant transcriptional regulatory proteins cause elevated drug resistance and overexpression of the ATP-binding cassette transporter-encoding gene, PDR5. We have carried out a genetic screen to identify negative regulators of PDR5 expression and found that loss of the mitochondrial genome (rho(o) cells) causes up-regulation of Pdr3p but not Pdr1p function. Additionally, loss of the mitochondrial inner membrane protein Oxa1p generates a signal that results in increased Pdr3p activity. Both of these mitochondrial defects lead to increased expression of the PDR3 structural gene. Importantly, the signaling pathway used to enhance Pdr3p function in rho(o) cells is not the same as in oxa1 cells. Loss of previously described nuclear-mitochondrial signaling genes like RTG1 reduce the level of PDR5 expression and drug resistance seen in rho(o) cells but has no effect on oxa1-induced phenotypes. These data uncover a new regulatory pathway connecting expression of multidrug resistance genes with mitochondrial function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In S. cerevisiae, dysfunctional mitochondria activate the pleiotropic drug resistance pathway for adaptation (13).”
From Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants (2013) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is consistent with reports for S. cerevisiae which demonstrate that dysfunctional mitochondria send a signal to the nucleus via a retrograde signaling pathway that leads to the over expression of many genes, including the pleiotropic drug resistance transcriptional factors, PDR1 and PDR3 (21, 73).”
From Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata : Roles of Calcium Signaling and Mitochondria (2004) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The activation of PDR3 further leads to transcriptional induction of genes encoding multidrug resistance pumps, including PDR5 (an S. cerevisiae homolog of Candida CDR1) (2, 21, 51, 73).”
From Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata : Roles of Calcium Signaling and Mitochondria (2004) · cites this paper as [21]
In the citing paper
“Such hyperactivation can be caused by gain-of-function (GOF) mutations in PDR1 or PDR314,15 or mitochondrial dysfunction (e.g. loss of the mitochondrial genome), the latter of which only stimulates Pdr3-dependent gene expression16.”
From SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes (2022) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sikorski, R. S., & Hieter, P. (1989) · Genetics · doi:10.1093/genetics/122.1.19 · Cited by 8,664
Transformation of intact yeast cells treated with alkali cations
Ito, H., Fukuda, Y., Murata, K., & Kimura, A. (1983) · Journal of Bacteriology · doi:10.1128/jb.153.1.163-168.1983 · Cited by 7,518
Sherman, F., Fink, G. R., & Hicks, J. B. (1979) · Cold Spring Harbor Laboratory eBooks · Cited by 7,430
Longtine, M. S., Mckenzie III, A., Demarini, D. J., Shah, N. G., Wach, A., Brachat, A., Philippsen, P., & Pringle, J. R. (1998) · Yeast · doi:10.1002/(sici)1097-0061(199807)14:10<953::aid-yea293>3.0.co;2-u · Cited by 5,345
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
New heterologous modules for classical or PCR‐based gene disruptions in Saccharomyces cerevisiae
Wach, A., Brachat, A., Pöhlmann, R., & Philippsen, P. (1994) · Yeast · doi:10.1002/yea.320101310 · Cited by 2,531
Gichner, T. (1982) · Biologia Plantarum · doi:10.1007/bf02909099 · Cited by 1,181
Martínez-Pastor, M. T., Marchler, G., Schüller, C., Marchler-Bauer, A., Ruis, H., & Estruch, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00576.x · Cited by 1,076
[10] Yeast promoters and lacZ fusions designed to study expression of cloned genes in yeast
Guarente, L. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)01013-7 · Cited by 1,071
Research works printed but not linked: 10
- 3. Grant, C.E. ∙ Valdimarsson, G. ∙ Hipfner, D.R. ... Cancer Res. 1994; 54:357-361 PubMed Google Scholar
- Katzmann, 1994, Mol. Cell. Biol., 14, 4653
- Gietz, 1995, Methods Mol. Cell Biol., 5, 255
- Wu, 1994, Mol. Cell. Biol., 14, 5832
- Tamai, 1994, Mol. Cell. Biol., 14, 8155
- Kim, 1986, Mol. Cell. Biol., 6, 1936
- Zhou, 1987, Gene, 15, 5261
- Friden, 1987, Mol. Cell. Biol., 7, 2708
- Johnston, 1987, Microbiol. Rev., 51, 458, 10.1128/mr.51.4.458-476.1987 · doi:10.1128/mr.51.4.458-476.1987 · Paper page
- Friden, 1989, Mol. Cell. Biol., 9, 4056
Cited by
Butow, R. A., & Avadhani, N. G. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00179-0 · Cited by 882
Mitochondrial retrograde signaling
Liu, Z., & Butow, R. A. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090613 · Cited by 680
Molecular basis of resistance to azole antifungals.
Lupetti, A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02280-3 · Cited by 449
De Clercq, I., Vermeirssen, V., Van Aken, O., Vandepoele, K., Murcha, M. W., Law, S. R., Inzé, A., Ng, S., Ivanova, A., Rombaut, D., et al. (2013) · The Plant Cell · doi:10.1105/tpc.113.117168 · Cited by 373
“…(the zinc finger transcription factor Pleiotropic Drug Resistance Protein3) is involved in an MRR response in which mitochondrial dysfunction triggers the expression of an ABC transporter involved in multidrug resistance (Hallstrom and Moye-Rowley, 2000; Traven et al., 2001; Devaux et al., 2002).”
BackgroundMitoCPR—A surveillance pathway that protects mitochondria in response to protein import stress
Weidberg, H., & Amon, A. (2018) · Science · doi:10.1126/science.aan4146 · Cited by 343
An update on antifungal targets and mechanisms of resistance in Candidaalbicans
Akins, R. A. (2005) · Medical Mycology · doi:10.1080/13693780500138971 · Cited by 291
Kushnir, S., Babiychuk, E., Storozhenko, S., Davey, M. W., Papenbrock, J., De Rycke, R., Engler, G., Stephan, U. W., Lange, H., Kispal, G., et al. (2001) · The Plant Cell · doi:10.1105/tpc.13.1.89 · Cited by 240
“The analysis of retrograde signaling in yeast, that is, modification of nuclear gene expression by multiple mitochondrial signals, has revealed the complex nature of the physiological processes that are induced by mitochondrial dysfunction (Hallstrom and Moye-Rowley, 2000).”
BackgroundTsai, H.-F., Krol, A. A., Sarti, K. E., & Bennett, J. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1384-1392.2006 · Cited by 237
“In that species, PDR3 was shown to be under positive autoregulation by Pdr3p (8), and retrograde signaling pathways have been shown to upregulate PDR3 expression in the petite mutants of S. cerevisiae (10, 12 ).”
BackgroundInfluentialShingu-Vazquez, M., & Traven, A. (2011) · Eukaryotic Cell · doi:10.1128/ec.05184-11 · Cited by 209
“In any case, activation of the drug resistance pathway by deletion of OXA1 appears to be distinct from that which occurs in cells that have lost mtDNA (35, 89).”
BackgroundInfluentialGulshan, K., & Moye-Rowley, W. S. (2007) · Eukaryotic Cell · doi:10.1128/ec.00254-07 · Cited by 182
“PDR1 expression levels are constant, whereas PDR3 is both autoregulated and highly induced in 0 cells (25, 44, 45).”
BackgroundThe retrograde response: When mitochondrial quality control is not enough
Jazwinski, S. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.02.010 · Cited by 172
“PDR5 is activated in rho cells by retrograde signaling and by mechanisms independent of the RTG genes in the presence of other mitochondrial defects [105].”
BackgroundLiu, C., Pouliot, J. J., & Nash, H. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182557199 · Cited by 171
Kaur, R., Castaño, I., & Cormack, B. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1600-1613.2004 · Cited by 167
“cerevisiae homolog of Candida CDR1) (2, 21, 51, 73).”
BackgroundInfluentialMembrane protein degradation by AAA proteases in mitochondria
Arnold, I., & Langer, T. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00267-7 · Cited by 150
Retrograde signaling is regulated by the dynamic interaction between Rtg2p and Mks1p
Liu, Z., Sekito, T., Špı́rek, M., Thornton, J., & Butow, R. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00285-5 · Cited by 148
Fungal ABC proteins: pleiotropic drug resistance, stress response and cellular detoxification
Wolfger, H., Mamnun, Y. M., & Kuchler, K. (2001) · Research in Microbiology · doi:10.1016/s0923-2508(01)01209-8 · Cited by 156
Multidrug resistance in fungi: regulation of transporter-encoding gene expression
Paul, S., & Moye-Rowley, W. S. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00143 · Cited by 137
“Screening a library of random transposon-induced null mutations to identify negative regulators of PDR5 expression uncovered an array of gene involved in maintaining the mitochondrial genome (Hallstrom and Moye-Rowley, 2000b).”
BackgroundBiogenesis of cytochrome c oxidase
Khalimonchuk, O., & Rödel, G. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.08.002 · Cited by 163
“RTG-independent pathways are operated by Gcn4p (Butow and Avadhani, 2004) or the closely related transcription factors, Pdr1p and Pdr3p (Hallstrom and Moye-Rowley, 2000; Butow and Avadhani, 2004).”
BackgroundAn evolutionary and functional assessment of regulatory network motifs
Mazurie, A., Bottani, S., & Vergassola, M. (2005) · Genome Biology · doi:10.1186/gb-2005-6-4-r35 · Cited by 138
“However, these two factors are used in response of two different cell signals: PDR3 is sensitive to mitochondrial activity, whereas PDR1 is not [42-44].”
BackgroundPeroxisome Biogenesis and Function
Kaur, N., Reumann, S., & Hu, J. (2009) · The Arabidopsis Book · doi:10.1199/tab.0123 · Cited by 139
“In budding yeast, respiratory defi - ciency in mitochondria results in retrograde regulation of nuclear genes, turning on a suite of genes associated with peroxisome biogenesis and proliferation (Hallstrom and Moye-Rowley, 2000; Epstein et al., 2001; Butow and Avadhani, 2004).”
Mamnun, Y. M., Pandjaitan, R., Mahé, Y., Delahodde, A., & Kuchler, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03262.x · Cited by 125
“Furthermore, Pdr3p is upregulated via these elements upon loss of mitochondrial function or lack of mitochondrial F o ATPase (Hallström and Moye-Rowley, 2000; Zhang and Moye-Rowley, 2001).”
BackgroundInfluentialThe Yeast Retrograde Response as a Model of Intracellular Signaling of Mitochondrial Dysfunction
Jazwinski, S. M., & Kriete, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00139 · Cited by 115
Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling
Edlind, T., Smith, L., Henry, K., Katiyar, S., & Nickels, J. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03165.x · Cited by 114
“In S. cerevisiae, mitochondrial defects have been shown to diminish azole sensitivity (Hallstrom and Moye-Rowley, 2000; Kontoyiannis, 2000), which would presumably offset the enhancing effects resulting from inhibition of Ca2+ signalling.”
BackgroundSekito, T. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-09-0473 · Cited by 108
“those that have lost their mitochondrial DNA ( petites), the expression of genes involved in anaplerotic pathways, small molecule transport, peroxisomal activities, and stress responses is up-regulated (Liao et al., 1991; Liu and Butow, 1999; Hallstrom and Moye-Rowley, 2000; Traven et al., 2000; Epstein et al., 2001).”
BackgroundTranscriptional Control of Multidrug Resistance in the Yeast Saccharomyces
Moye-Rowley, S. (2003) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(03)01008-0 · Cited by 114
Owsianik, G., Balzi, L., & Ghislain, M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02823.x · Cited by 106
“On the other hand, Pdr3p, but not Pdr1p, is activated after loss of the mitochondrial genome (Hallstrom and Moye-Rowley, 2000b).”
BackgroundThomas, E., Roman, E., Claypool, S., Manzoor, N., Pla, J., & Panwar, S. L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00889-13 · Cited by 105
“glabrata indicate that loss of mitochondrial function leads to an elevated expression of the ABC transporter genes (ScPDR5, CgCDR1, and CgCDR2) via transcription factors ScPdr3 and CgPdr1, causing the multidrug resistance (MDR) phenotype (39, 40, 73, 74).”
BackgroundDerivatives of Rhodamine 19 as Mild Mitochondria-targeted Cationic Uncouplers
Antonenko, Y. N., Avetisyan, A. V., Cherepanov, D. A., Кнорре, Д. А., Korshunova, G. A., Маркова, О. В., Ojovan, S. M., Perevoshchikova, I. V., Pustovidko, A. V., Rokitskaya, T. I., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212837 · Cited by 104
Rogers, P. D., & Barker, K. S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3412-3417.2002 · Cited by 94
Sun, N., Fonzi, W., Chen, H., She, X., Zhang, L., Zhang, L., & Calderone, R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01520-12 · Cited by 94
“(ii) Cell energy output is definitely reduced in the goa1 mutant (13), but less is known about this phenotype in the ndh51 mutant.”
BackgroundInfluentialSensing, signaling and surviving mitochondrial stress
Eckl, E.-M., Ziegemann, O., Krumwiede, L., Fessler, E., & Jae, L. T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03887-7 · Cited by 100
“Pdr3 has previously also been described to alter gene expression following electron transport chain defects and mtDNA loss [99].”
BackgroundMitochondrial dysfunctions trigger the calcium signaling-dependent fungal multidrug resistance
Li, Y., Zhang, Y., Zhang, C., Wang, H., Wei, X., Chen, P., & Lu, L. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911560116 · Cited by 86
Genome‐wide studies on the nuclear PDR3‐controlled response to mitochondrial dysfunction in yeast
Devaux, F., Carvajal, E., Moye-Rowley, S., & Jacq, C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02387-6 · Cited by 85
Azole Resistance in Candida glabrata
Whaley, S. G., & Rogers, P. D. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0554-5 · Cited by 85
Coordinate Control of Sphingolipid Biosynthesis and Multidrug Resistance in Saccharomyces cerevisiae
Hallstrom, T. C., Lambert, L., Schorling, S., Balzi, E., Goffeau, A., & Moye-Rowley, W. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101568200 · Cited by 82
Self-citationZhang, X., & Moye-Rowley, W. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106285200 · Cited by 84
Regulation of the CgPdr1 Transcription Factor from the Pathogen Candida glabrata
Paul, S., Schmidt, J. A., & Moye-Rowley, W. S. (2011) · Eukaryotic Cell · doi:10.1128/ec.00277-10 · Cited by 78
“cerevisiae established that 0 cells induce expression of the CgCDR1 homologue ScPDR5 gene at the level of the promoter (14, 41).”
BackgroundGoldstein, A. L., & McCusker, J. H. (2001) · Genetics · doi:10.1093/genetics/159.2.499 · Cited by 75
Singh, A., Yadav, V., & Prasad, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039812 · Cited by 72
Retrograde regulation of multidrug resistance in Saccharomyces cerevisiae
Moye-Rowley, S. (2005) · Gene · doi:10.1016/j.gene.2005.03.019 · Cited by 78
Mitochondria-cytosol-nucleus crosstalk: learning from Saccharomyces cerevisiae
Guaragnella, N., Coyne, L. P., Chen, X. J., & Giannattasio, S. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy088 · Cited by 72
Mamnun, Y. M., Schüller, C., & Kuchler, K. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00046-8 · Cited by 70
McLaughlin, J. E., Bin-Umer, M. A., Tortora, A., Mendez, N., McCormick, S. P., & Tumer, N. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909777106 · Cited by 71
“Loss of mitochondrial genome (rho0) is known to activate the pleiotropic drug resistance pathway via the overexpression of PDR5, the gene encoding the ATP-binding cassette transporter (25).”
BackgroundInfluentialVerma, S., Shakya, V. P. S., & Idnurm, A. (2018) · Virulence · doi:10.1080/21505594.2017.1414133 · Cited by 67
“Mitochondrial-nuclear crosstalk has important implications in drug resistance [75].”
BackgroundInfluentialJazwinski, S. M. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00005-2 · Cited by 67
Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata
Tscherner, M., Schwarzmüller, T., & Kuchler, K. (2011) · Pharmaceuticals · doi:10.3390/ph4010169 · Cited by 59
“glabrata [108-110].”
Lee, W., Choi, H.-I., Kim, M. J., & Park, S. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.1.109 · Cited by 65
“…colleagues also reported that multiple signals from dysfunctional mitochondria activate the pleiotropic drug resistance pathway in S. cerevisiae (Hallstrom and Moye-Rowley, 2000; Moye-Rowley, 2005), it is not clear whether the mtDNA-depletion is a contributing factor in the expression of…”
BackgroundDunn, C. D., & Jensen, R. E. (2003) · Genetics · doi:10.1093/genetics/165.1.35 · Cited by 64
Drug resistance in yeasts — an emerging scenario
Prasad, R., Panwar, S. L., & Smriti, S. (2002) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(02)46004-3 · Cited by 69
Differential Regulation of Ceramide Synthase Components LAC1 and LAG1 in Saccharomyces cerevisiae
Kolaczkowski, M., Kolaczkowska, A., Gaigg, B., Schneiter, R., & Moye-Rowley, W. S. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.4.880-892.2004 · Cited by 62
“The increase of LAC1 mRNA in 0 cells required the presence of wild-type PDR3, consistent with the idea that LAC1 is a downstream target of Pdr3p-dependent retrograde regulation, as seen previously for IPT1 (23) and PDR5 (25).”
MethodShahi, P., & Moye-Rowley, W. S. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.12.012 · Cited by 57
“Cells that have lost their mitochondrial genome (ρ cells) strongly induce levels of Sc PDR5 in a ScPdr3-dependent manner [30].”
Qu, Y., Jelicic, B., Pettolino, F., Perry, A., Lo, T. L., Hewitt, V. L., Bantun, F., Beilharz, T. H., Peleg, A. Y., Lithgow, T., et al. (2012) · Eukaryotic Cell · doi:10.1128/ec.05292-11 · Cited by 57
Lucau-Danila, A., Delaveau, T., Lelandais, G., Devaux, F., & Jacq, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309580200 · Cited by 59
Sellem, C. H., Marsy, S., Boivin, A., Lemaire, C., & Sainsard‐Chanet, A. (2006) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2006.09.005 · Cited by 58
Kolaczkowska, A., Kolaczkowski, M., Goffeau, A., & Moye-Rowley, W. S. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.045 · Cited by 55
“Centromeric PDR5, YOR1, and PDR3 b-galactosidase reporter plasmids were described previously [10,16].”
BackgroundSchüller, C., Mamnun, Y. M., Wolfger, H., Rockwell, N., Thorner, J., & Kuchler, K. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0610 · Cited by 55
“In fact, Pdr3, but not Pdr1, is specifically and rapidly activated by mitochondrial malfunction (Hallström and Moye-Rowley, 2000), suggesting a distinct mechanism for the Pdr1-dependent activation by DCP. Pdr1 and/or Pdr3 could also respond to lipid degradation products generated during the repair…”
BackgroundGuaragnella, N., & Butow, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309301200 · Cited by 53
Cross-talk between Transcriptional Regulators of Multidrug Resistance in Saccharomyces cerevisiae
Zhang, X., Cui, Z., Miyakawa, T., & Moye-Rowley, W. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010686200 · Cited by 55
Antifungal resistance in Aspergillus terreus: A current scenario
Vahedi‐Shahandashti, R., & Lass‐Flörl, C. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103247 · Cited by 55
The Regulatory Role of Key Metabolites in the Control of Cell Signaling
Milanesi, R., Coccetti, P., & Tripodi, F. (2020) · Biomolecules · doi:10.3390/biom10060862 · Cited by 55
Arnold, I., Wagner-Ecker, M., Ansorge, W. J., & Langer, T. (2006) · Gene · doi:10.1016/j.gene.2005.09.044 · Cited by 57
Panwar, S. L., & Moye-Rowley, W. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512115200 · Cited by 51
Shahi, P., Gulshan, K., Näär, A. M., & Moye-Rowley, W. S. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-10-0899 · Cited by 49
“Our previous work has demonstrated that loss of the mitochondrial genome ( 0 cells) strongly induced the activity of wild-type Pdr3, which in turn stimulated PDR5 transcription (Hallstrom and Moye-Rowley, 2000; Zhang and Moye-Rowley, 2001).”
BackgroundMethodBadrane, H., Cheng, S., Dupont, C., Hao, B., Driscoll, E., Morder, K., Liu, G., Newbrough, A., Fleres, G., Kaul, D., et al. (2023) · doi:10.21203/rs.3.rs-2706400/v1 · Cited by 48
“Regardless of mechanism, dysfunctional mitochondria activate compensatory responses that confer adaptive advantages with cross-resistance to both azole and phagocytic killing 21,37,38 .”
Keller, G., Ray, E., Brown, P. O., & Winge, D. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107131200 · Cited by 47
Liu, S., Liu, S., & Jiang, H. (2021) · FEBS Journal · doi:10.1111/febs.16323 · Cited by 51
Friis, R. M. N., Glaves, J. P., Huan, T., Li, L., Sykes, B. D., & Schultz, M. C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.029 · Cited by 44
Gulshan, K., Schmidt, J. A., Shahi, P., & Moye-Rowley, W. S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00405-08 · Cited by 46
“This behavior is strikingly similar to the Pdr3mediated activation of PDR5 expression that occurs in [rho0] cells ( 18 ).”
BackgroundResultInfluentialCan Saccharomyces cerevisiae keep up as a model system in fungal azole susceptibility research?
Demuyser, L., & Dijck, P. V. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.02.002 · Cited by 46
The lipid-translocating exporter family and membrane phospholipid homeostasis in yeast
Manente, M., & Ghislain, M. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00513.x · Cited by 49
A Novel Degron-mediated Degradation of the RTG Pathway Regulator, Mks1p, by SCFGrr1
Liu, Z., Spírek, M., Thornton, J., & Butow, R. A. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0516 · Cited by 43
“In the budding yeast, Saccharomyces cerevisiae, the loss of respiratory activity results in increased expression of a defined set of nuclear genes encoding proteins that participate in activities that include anaplerotic pathways, peroxisome biogenesis, small molecule transport systems and pleiotropic drug resistance…”
BackgroundIdentification and Analysis of Cation Channel Homologues in Human Pathogenic Fungi
Prole, D. L., & Taylor, C. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042404 · Cited by 41
“several fungi [145–147], suggesting that fungal homologues of MCU may be attractive novel targets for anti-fungal drugs.”
BackgroundPrunuske, A. J., Waltner, J. K., Kuhn, P., Gu, B., & Craig, E. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119184109 · Cited by 41
“Conversely, Pdr3, but not Pdr1, is activated by a yet-to-be-defined signal present in cells lacking a functional mitochondrial genome (10).”
BackgroundHow do yeast sense mitochondrial dysfunction?
Кнорре, Д. А., Соколов, С. С., Zyrina, A. N., & Severin, F. F. (2016) · Microbial Cell · doi:10.15698/mic2016.11.537 · Cited by 43
“Thus, one of the responses induced by Rtg1/Rtg3 transcription factors is the induction of pleiotropic ABC-transporters expression, that can prevent the delivery of unwanted xenobiotics to mitochondrial targets [24], although the precise mechanism of pleiotropic drug resistance activation is still unknown [15].”
Interaction between Rtg2p and Mks1p in the regulation of the RTG pathway of Saccharomyces cerevisiae
Ferreira-Júnior, J. R., Špírek, M., Liu, Z., & Butow, R. A. (2005) · Gene · doi:10.1016/j.gene.2005.03.048 · Cited by 40
Niimi, M., Nagai, Y., Niimi, K., Wada, S.-I., Cannon, R. D., Uehara, Y., & Monk, B. C. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00668-2 · Cited by 40
Zhang, X., Kolaczkowska, A., Devaux, F., Panwar, S. L., Hallstrom, T. C., Jacq, C., & Moye-Rowley, W. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408333200 · Cited by 35
Self-citationDemuyser, L., Swinnen, E., Fiori, A., Herrera-Malaver, B., Verstrepen, K., & Van Dijck, P. (2017) · mBio · doi:10.1128/mbio.00201-17 · Cited by 33
“cerevisiae mutant strain grows in the presence of an otherwise inhibitory chemical, it is important to consider increased rho0/ formation and drug efflux as possible modes of action (60).”
Replicative aging as a source of cell heterogeneity in budding yeast
Кнорре, Д. А., Azbarova, A. V., Galkina, K. V., Feniouk, B. A., & Severin, F. F. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.09.001 · Cited by 33
Dhar, R., Missarova, A., Lehner, B., & Carey, L. B. (2019) · eLife · doi:10.7554/elife.38904 · Cited by 37
“9 tolerance to some antifungal drugs [55-57] and respiration deficient strains are often isolated 226 from drug-treated patients [58-60].”
BackgroundThe Biogenesis of Cellular Organelles
Mullins, C. (2005) · Springer eBooks · doi:10.1007/b138220 · Cited by 44
Negative Transcriptional Regulation of Multidrug Resistance Gene Expression by an Hsp70 Protein
Shahi, P., Gulshan, K., & Moye-Rowley, W. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704772200 · Cited by 34
Batova, M., Borecka-Melkusova, S., Simockova, M., Dzugasova, V., Goffa, E., & Subik, J. (2008) · Current Genetics · doi:10.1007/s00294-008-0187-9 · Cited by 31
“…as a single orthologue of homologous ScPDR1 and ScPDR3 genes apparently fulWls the role of the ScPDR3 gene that is autoregulated by Pdr3p after its activation by retrograde signaling from dysfunctional mitochondria (Hallstrom and Moye-Rowley 2000; Zhang and Moye-Rowley 2001; Moye-Rowley 2005).”
BackgroundJazwinski, S. M. (2011) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-2561-4_4 · Cited by 34
Xu, Z. Q., Zhang, L., Zhang, J., Cao, Y., Yu, Y.-Y., Wang, D., Ying, K., Chen, W., & Jiang, Y. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2006.03.004 · Cited by 33
“Impairment or loss of mitochondrial function was reported to be associated with increased expression of Pdr5p in S. cerevisiae (Hallstrom and Moye-Rowley, 2000).”
BackgroundBillmyre, R. B., Craig, C. J., Lyon, J. W., Reichardt, C., Kuhn, A. M., Eickbush, M. T., & Zanders, S. E. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003184 · Cited by 32
“In S. cerevisiae , mitochondrial disfunction induces expression of pleiotropic drug efflux pumps [63].”
Moye-Rowley, S. (2018) · Current Genetics · doi:10.1007/s00294-018-0870-4 · Cited by 32
Kotiadis, V. N., Leadsham, J. E., Bastow, E. L., Gheeraert, A., Whybrew, J. M., Bard, M., Lappalainen, P., & Gourlay, C. W. (2012) · Journal of Cell Science · doi:10.1242/jcs.099390 · Cited by 38
“, 2010) and PDR5 transcription (Hallstrom and Moye-Rowley, 2000) have been described previously.”
BackgroundMethodPdr3 is required for DNA damage induction of MAG1 and DDI1 via a bi-directional promoter element
Zhu, Y., & Xiao, W. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh838 · Cited by 32
“It was also shown that the activation of PDR5 by mitochondrial defects required the presence of PDR3 but not PDR1 (44).”
BackgroundInfluentialWeerasinghe, H., Stölting, H., Rose, A. J., & Traven, A. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00171-22 · Cited by 31
Nishida‐Aoki, N., Dongyu, J., Kuroda, K., & Ueda, M. (2013) · Current Genetics · doi:10.1007/s00294-013-0419-5 · Cited by 30
yMGV: helping biologists with yeast microarray data mining
Crom, S. L., Devaux, F., Jacq, C., & Marc, P. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.76 · Cited by 29
“PDR3 transcription is specifically activated in cells that lack the mitochondrial genome (11), but the mechanisms responsible for this activation are unknown.”
BackgroundPodholová, K., Plocek, V., Rešetárová, S., Kučerová, H., Hlaváček, O., Váchová, L., & Palková, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.8084 · Cited by 27
“In addition, RTG gene-independent mitochondriato-nucleus signaling has been proposed in yeast [13, 14].”
BackgroundInsights into the Multi-Azole Resistance Profile in Candida haemulonii Species Complex
Silva, L. N., Ramos, L. S., de Oliveira, S. S. C., Magalhães, L. B., Squizani, E. D., Kmetzsch, L., Vainstein, M. H., Branquinha, M. H., & dos Santos, A. L. S. (2020) · Journal of Fungi · doi:10.3390/jof6040215 · Cited by 27
“fumigatus, mitochondrial dysfunction has displayed multiple effects in fungal cells, and this can enlighten us on the enhanced efflux pumps’ activities [53,56,57].”
BackgroundJazwinski, S. M. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.12.007 · Cited by 29
Khakhina, S., Simonicova, L., & Moye‐Rowley, W. S. (2018) · Molecular Microbiology · doi:10.1111/mmi.13913 · Cited by 32
“Previously, we have shown that ScPdr3 can activate its target gene suites via engagement with either Med15- or Med12dependent mechanisms (Shahi et al., 2010).”
BackgroundMethodGiudice, L. D., Massardo, D. R., Pontieri, P., & WOLF, K. W. (2005) · Gene · doi:10.1016/j.gene.2005.03.020 · Cited by 32
Stribinskis, V., Heyman, H., Ellis, S. R., Steffen, M. C., & Martín, N. C. R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6546-6558.2005 · Cited by 27
“Disruption of ADA3 leads to diminished transcription by Gcn4p (50) but enhanced transcription by Gal4p, Pdr1p, and Pdr3p (6, 42).”
BackgroundDivergence in a master variator generates distinct phenotypes and transcriptional responses
Gallagher, J. E. G., Zheng, W., Rong, X., Miranda, N., Lin, Z., Dunn, B. L., Zhao, H., & Snyder, M. P. (2014) · Genes & Development · doi:10.1101/gad.228940.113 · Cited by 27
van Leeuwen, J. S., Orij, R., Luttik, M. A. H., Smits, G. J., Vermeulen, N. P. E., & Vos, J. C. (2010) · Microbiology · doi:10.1099/mic.0.044578-0 · Cited by 26
“Furthermore, upregulation of the PDR multidrug response in rho cells (Table 1) (Hallstrom and Moye-Rowley, 2000) may contribute to the resistance.”
Background
Metadata
- Authors
- Hallstrom, T. C., & Moye-Rowley, W. S.
- Affiliations
- University of Iowa (US)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 275
- Issue
- 48
- Pages
- 37347-37356
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1999757563
- Cited by
- 194
- References
- 61
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 10 · 2023: 9 · 2022: 3 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 16 · 2017: 5 · 2016: 6 · 2014: 10 · 2013: 8 · 2012: 10
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7244 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM049825, GM49825)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- pleiotropic drug resistance, Pdr1p, PDR5, ABC transporters, mitochondrial dysfunction, Saccharomyces cerevisiae, transcriptional regulation, multidrug resistance genes
- MeSH terms
- Base Sequence, Drug Resistance, Microbial, Genes, Fungal, Membrane Proteins, Mitochondria, Saccharomyces cerevisiae, Signal Transduction, DNA Primers, ATP-Binding Cassette Transporters, Saccharomyces cerevisiae Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.